FMWA
PRPH

Forvis Mazars Wealth Advisors’s ProPhase Labs PRPH Stock Holding History

Forvis Mazars Wealth Advisors’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,960
Closed -$8.97K – 414
2025
Q3 		$8.97K Hold
1,960
– – ﹤0.01% 402
2025
Q2 		$7.67K Buy
+1,960
New +$6.56K ﹤0.01% 396

Other funds holding PRPH

SC
Sykon Capital Harrison, New York $325M AUM 19.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Forvis Mazars Wealth Advisors's PRPH Position: Q4 2025 in Review

Forvis Mazars Wealth Advisors sold out of ProPhase Labs (PRPH) in Q4 2025, closing a stake of 1,960 shares — an estimated $8.97K sold.

Forvis Mazars Wealth Advisors first reported a position in PRPH in Q2 2025 and held it in 2 quarters. The position peaked at $8.97K in Q3 2025. 17 funds tracked by Wall St. Rank hold PRPH as of Q4 2025.

  • Forvis Mazars Wealth Advisors reported no remaining ProPhase Labs position as of Q4 2025 after selling out during the quarter.
  • Forvis Mazars Wealth Advisors sold 1,960 ProPhase Labs shares in Q4 2025, an estimated $8.97K.
  • Forvis Mazars Wealth Advisors first reported a position in ProPhase Labs in Q2 2025 and held it in 2 quarters.
  • Forvis Mazars Wealth Advisors's ProPhase Labs position peaked at $8.97K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2025.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.